Yuyu Pharma Inc (000227) - Total Liabilities

Latest as of September 2025: ₩63.32 Billion KRW ≈ $42.91 Million USD

Based on the latest financial reports, Yuyu Pharma Inc (000227) has total liabilities worth ₩63.32 Billion KRW (≈ $42.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Yuyu Pharma Inc operating cash flow efficiency to assess how effectively this company generates cash.

Yuyu Pharma Inc - Total Liabilities Trend (2014–2024)

This chart illustrates how Yuyu Pharma Inc's total liabilities have evolved over time, based on quarterly financial data. Check Yuyu Pharma Inc (000227) asset resilience to evaluate the company's liquid asset resilience ratio.

Yuyu Pharma Inc Competitors by Total Liabilities

The table below lists competitors of Yuyu Pharma Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Estoril Sol SGPS SA LS:ESON	Portugal	€189.46 Million
Hyungkuk F&B Co Ltd KQ:189980	Korea	₩134.09 Billion
Oceanpal Inc NASDAQ:OP	USA	$4.10 Million
Adaptimmune Therapeutics plc F:473A	Germany	€201.59 Million
Imago Mulia Persada Tbk PT JK:LFLO	Indonesia	Rp89.24 Billion
AXIOS Sustainable Growth NYSE:AXAC	USA	$1.18 Million
Cengild Medical Berhad KLSE:0243	Malaysia	RM101.09 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Yuyu Pharma Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yuyu Pharma Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yuyu Pharma Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yuyu Pharma Inc (2014–2024)

The table below shows the annual total liabilities of Yuyu Pharma Inc from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩72.62 Billion ≈ $49.22 Million	-6.72%
2023-12-31	₩77.86 Billion ≈ $52.76 Million	+8.39%
2022-12-31	₩71.83 Billion ≈ $48.68 Million	+11.71%
2021-12-31	₩64.30 Billion ≈ $43.58 Million	+69.82%
2020-12-31	₩37.86 Billion ≈ $25.66 Million	-19.73%
2019-12-31	₩47.17 Billion ≈ $31.97 Million	-2.44%
2018-12-31	₩48.35 Billion ≈ $32.77 Million	+25.08%
2017-12-31	₩38.66 Billion ≈ $26.20 Million	+17.11%
2016-12-31	₩33.01 Billion ≈ $22.37 Million	+7.88%
2015-12-31	₩30.60 Billion ≈ $20.73 Million	+2.29%
2014-12-31	₩29.91 Billion ≈ $20.27 Million	--

About Yuyu Pharma Inc

KO:000227 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$42.93 Million

₩63.34 Billion KRW

Market Cap Rank

#22443 Global

#1518 in Korea

Share Price

₩10810.00

Change (1 day)

-0.37%

52-Week Range

₩9900.00 - ₩11670.00

All Time High

₩56262.57